Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check7 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision label updates from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe study record view displays a 403 Forbidden message and a Home link instead of study information.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected study record content. This indicates restricted access or an issue with the site that prevents viewing the study details.SummaryDifference18%

- Check56 days agoChange DetectedAdded a note for 2014 ( U.S. NIH Grant/Contract ) and updated the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now includes additional data-sharing information and links to the Statistical Analysis Plan and Study Protocol, expanding context for researchers, and an error page indicating an outage was removed, restoring access to the study record.SummaryDifference100%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.